Plasma Protease C1-inhibitor Treatment Market
1 STUDY COVERAGE
1.1 Plasma Protease C1-inhibitor Treatment Product Introduction
1.2 Market by Type
1.2.1 United States Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Type1
1.2.3 Type2
1.3 Market by Application1.3.1 United States Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Application 1
1.3.3 Application 2
1.4 United States Plasma Protease C1-inhibitor Treatment Sales Estimates and Forecasts 2017-20281.5 United States Plasma Protease C1-inhibitor Treatment Hydrocephalus Shunts Revenue Estimates and Forecasts 2017-2028
1.6 Study Objectives
1.7 Years Considered
2 COMPETITION BY MANUFACTURERS
2.1 United States Plasma Protease C1-inhibitor Treatment Sales by Manufacturers
2.1.1 United States Plasma Protease C1-inhibitor Treatment Sales by Manufacturers (2017-2022)2.1.2 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Manufacturers (2017-2022)
2.1.3 Top Largest Manufacturers of Plasma Protease C1-inhibitor Treatment in 2021 in United States2.2 United States Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers
2.2.1 United States Plasma Protease C1-inhibitor Treatment Revenue by Manufacturers (2017-2022)2.2.2 United States Plasma Protease C1-inhibitor Treatment Revenue Market Share by Manufacturers (2017-2022)
2.2.3 United States Top Companies by Plasma Protease C1-inhibitor Treatment Revenue in 20212.3 United States Plasma Protease C1-inhibitor Treatment Sales Price by Manufacturers (2017-2022)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)2.4.2 United States Plasma Protease C1-inhibitor Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 United States Plasma Protease C1-inhibitor Treatment Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 UNITED STATES Plasma Protease C1-inhibitor Treatment MARKET SIZE BY REGION
3.1 Plasma Protease C1-inhibitor Treatment Market Size by Region: 2017-2028
3.1.1 United States Plasma Protease C1-inhibitor Treatment Sales by Region: 2017-20223.1.2 United States Plasma Protease C1-inhibitor Treatment Sales Forecast by Region (2023-2028)
3.1.3 United States Plasma Protease C1-inhibitor Treatment Revenue by Region: 2017-2022
3.1.4 United States Plasma Protease C1-inhibitor Treatment Revenue Forecast by Region (2023-2028)3.2 Northeast Plasma Protease C1-inhibitor Treatment Sales and Revenue Growth (2017-2028)
3.3 South Plasma Protease C1-inhibitor Treatment Sales and Revenue Growth (2017-2028)
3.4 Midwest Plasma Protease C1-inhibitor Treatment Sales and Revenue Growth (2017-2028)3.5 West Plasma Protease C1-inhibitor Treatment Sales and Revenue Growth (2017-2028)
4 MARKET SIZE BY TYPE
4.1 United States Plasma Protease C1-inhibitor Treatment Sales by Type4.1.1 United States Plasma Protease C1-inhibitor Treatment Historical Sales by Type (2017-2022)
4.1.2 United States Plasma Protease C1-inhibitor Treatment Forecasted Sales by Type (2023-2028)
4.1.3 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Type (2017-2028)4.2 United States Plasma Protease C1-inhibitor Treatment Revenue by Type
4.2.1 United States Plasma Protease C1-inhibitor Treatment Historical Revenue by Type (2017-2022)
4.2.2 United States Plasma Protease C1-inhibitor Treatment Forecasted Revenue by Type (2023-2028)4.2.3 United States Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2017-2028)
4.3 United States Plasma Protease C1-inhibitor Treatment Price by Type
4.3.1 United States Plasma Protease C1-inhibitor Treatment Price by Type (2017-2022)4.3.2 United States Plasma Protease C1-inhibitor Treatment Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION
5.1 United States Plasma Protease C1-inhibitor Treatment Sales by Application5.1.1 United States Plasma Protease C1-inhibitor Treatment Historical Sales by Application (2017-2022)
5.1.2 United States Plasma Protease C1-inhibitor Treatment Forecasted Sales by Application (2023-2028)
5.1.3 United States Plasma Protease C1-inhibitor Treatment Sales Market Share by Application (2017-2028)5.2 United States Plasma Protease C1-inhibitor Treatment Revenue by Application
5.2.1 United States Plasma Protease C1-inhibitor Treatment Historical Revenue by Application (2017-2022)
5.2.2 United States Plasma Protease C1-inhibitor Treatment Forecasted Revenue by Application (2023-2028)5.2.3 United States Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2017-2028)
5.3 United States Plasma Protease C1-inhibitor Treatment Price by Application
5.3.1 United States Plasma Protease C1-inhibitor Treatment Price by Application (2017-2022)5.3.2 United States Plasma Protease C1-inhibitor Treatment Price Forecast by Application (2023-2028)
6 CORPORATE PROFILE
6.1 Company16.1.1 Company 1 Corporation Information
6.1.2 Company 1 Overview
6.1.3 Company 1 in United States: Plasma Protease C1-inhibitor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)6.1.4 Company 1 Plasma Protease C1-inhibitor Treatment Product Introduction
6.1.5 Company 1 Recent Developments
6.2 Company 2
6.2.1 Company 2 Corporation Information
6.2.2 Company 2 Overview6.2.3 Company 2 in United States: Plasma Protease C1-inhibitor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
6.2.4 Company 2 Plasma Protease C1-inhibitor Treatment Product Introduction
6.2.5 Company 2 Recent Developments
6.3 Company 3
6.3.1 Company 3 Corporation Information6.3.2 Company 3 Overview
6.3.3 Company 3 in United States: Plasma Protease C1-inhibitor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
6.3.4 Company 3 Plasma Protease C1-inhibitor Treatment Product Introduction
6.3.5 Company 3 Recent Developments
6.4 Company 36.4.1 Company 4 Corporation Information
6.4.2 Company 4 Overview
6.4.3 Company 4 in United States: Plasma Protease C1-inhibitor Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
6.4.4 Company 4 Plasma Protease C1-inhibitor Treatment Product Introduction
6.4.5 Company 4 Recent Developments
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Plasma Protease C1-inhibitor Treatment Industry Chain Analysis
7.2 Plasma Protease C1-inhibitor Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers7.3 Plasma Protease C1-inhibitor Treatment Production Mode & Process
7.4 Plasma Protease C1-inhibitor Treatment Sales and Marketing
7.4.1 Plasma Protease C1-inhibitor Treatment Sales Channels
7.4.2 Plasma Protease C1-inhibitor Treatment Distributors
7.5 Plasma Protease C1-inhibitor Treatment Customers
8 Plasma Protease C1-inhibitor Treatment MARKET DYNAMICS
8.1.1 Plasma Protease C1-inhibitor Treatment Industry Trends
8.1.2 Plasma Protease C1-inhibitor Treatment Market Drivers
8.1.3 Plasma Protease C1-inhibitor Treatment Market Challenges
8.1.4 Plasma Protease C1-inhibitor Treatment Market Restraints
9 KEY FINDINGS IN THE UNITED STATES Plasma Protease C1-inhibitor Treatment STUDY
10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of C1-inhibitors
Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2022)
Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2023-2028)
Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2017-2022)
Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2017-2022)
Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2023-2028)
Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Takeda Company Detail
Table 42. Takeda Business Overview
Table 43. Takeda Plasma Protease C1-inhibitor Treatment Product
Table 44. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 45. Takeda Recent Development
Table 46. CSL Company Detail
Table 47. CSL Business Overview
Table 48. CSL Plasma Protease C1-inhibitor Treatment Product
Table 49. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 50. CSL Recent Development
Table 51. Sanquin Company Detail
Table 52. Sanquin Business Overview
Table 53. Sanquin Plasma Protease C1-inhibitor Treatment Product
Table 54. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 55. Sanquin Recent Development
Table 56. Pharming Group Company Detail
Table 57. Pharming Group Business Overview
Table 58. Pharming Group Plasma Protease C1-inhibitor Treatment Product
Table 59. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 60. Pharming Group Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2021 VS 2028
Figure 2. C1-inhibitors Features
Figure 3. Kallikrein Inhibitor (Kalbitor) Features
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Independent Pharmacies and Outlets Case Studies
Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2021 VS 2028
Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2021
Figure 12. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2021
Figure 14. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 16. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 20. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2028)
Figure 28. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 36. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2017-2028)
Figure 40. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 43. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 44. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 45. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Industry Market Size
